Lyfegen
Financial Software · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Aeschenvorstadt, Basel, Basel-City, 4051...Website
www.lyfegen.comRevenue
$8.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
2
1
1
About Lyfegen
Lyfegen is an independent provider of rebate management software designed for the healthcare industry. Lyfegen solutions are used by health insurances, governments, hospital payers, and pharmaceutical companies around the globe to dramatically reduce the administrative burden of managing complex drug pricing agreements and to optimize rebates and get better value from those agreements. Lyfegen maintains the world's largest digital repository of innovative drug pricing models and public agreements and offers access to a robust drug pricing simulator designed to dynamically simulate complex drug pricing scenarios to understand the full financial impact. Headquartered in Basel, Switzerland, the company was founded in 2018 and has a market presence in Europe, North America, and the Middle East.Explore more
Lyfegen Org Chart
LB
Team Lead Senior QA Engineer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lyfegen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Lyfegen has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Lyfegen has new funding data
Congratulate Masked Content for being promoted to Masked Content at Lyfegen
Check out if Lyfegen is spiking on competitors!
Product Launch: Get notified when Lyfegen launches new products
Earning: See what the market has to say on Lyfegen recently announced quarterly report
Click to see if Lyfegen had a recent Job posting/layoffs
Lyfegen, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Lyfegen
Compare insights from companies similar to Lyfegen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$13.6M
51-200
Private
-
1984
CO
Charles OlesonVice President and Chief Information Officer, Butler Health System
Company Profile Activity
Activity Insights
Lyfegen is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Lyfegen is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Lyfegen.
Lyfegen financials insights
Gather financial insights about Lyfegen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$8M
2024
Series A
$5.6M
Lyfegen Tech Stack
A closer look at the technologies used by Lyfegen
Most Recent Scoops
Open Position
Hiring Plans
Lyfegen has more open roles in Engineering & Technical than it has had at any time in the past 9 months.
Hiring Plans
Open Position
Open Position
Hiring Plans
Hiring Plans
Top Financial Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lyfegen
Sign Up For FreeTo access detailed company insights
Lyfegen is an independent provider of rebate management software designed for the healthcare industry. Lyfegen solutions are used by health insurances, governments, hospital payers, and pharmaceutical companies around the globe to dramatically reduce the administrative burden of managing complex drug pricing agreements and to optimize rebates and g... Read More
